Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study.
about
Treatment of multiple sclerosis in Germany: an analysis based on claims data of more than 30,000 patients.Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study.Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort studyHospitalization rates and discharge status in multiple sclerosisRetrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.Determinants of high cost in multiple sclerosis patients: a claims and chart review study.Being Kind to Your Future Self: Probability Discounting of Health Decision-Making.Peginterferon beta-1a versus other self-injectable disease-modifying therapies in the treatment of relapsing-remitting multiple sclerosis in Scotland: a cost-effectiveness analysis.A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records.Rates of Early Treatment for US Veterans With Multiple Sclerosis.
P2860
Q30672336-29EFA326-D329-4A27-B2F2-C82A82248CFFQ35091777-1D37908F-652C-4129-9FF8-966868C29D01Q35388991-117549A8-C41C-4F2F-A202-27FF9E64278AQ36882707-FEBE0B71-A8FC-47AF-BBED-B3870E4D800FQ37501092-EC5BDDB1-F4C3-4F35-BC5C-4C991D5B092EQ38840408-7B1F49F0-CD7D-4ABD-83E9-8CABC72BF295Q38931794-215EB8C8-AE4E-45D5-AF49-49A66DC3C623Q39300217-CDC381F6-4F48-4E4C-97A2-F9ACD6B6C0F1Q42953393-8F130F3A-D4D6-4088-836E-A55EA1F3623AQ48680967-65D13BC8-BBAE-4B95-B26B-CFB5986DCBCBQ55364417-F95204BB-5D58-4376-B595-0000AA0F3525
P2860
Disease-modifying drug initiation patterns in commercially insured multiple sclerosis patients: a retrospective cohort study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Disease-modifying drug initiat ...... a retrospective cohort study.
@ast
Disease-modifying drug initiat ...... a retrospective cohort study.
@en
Disease-modifying drug initiat ...... a retrospective cohort study.
@nl
type
label
Disease-modifying drug initiat ...... a retrospective cohort study.
@ast
Disease-modifying drug initiat ...... a retrospective cohort study.
@en
Disease-modifying drug initiat ...... a retrospective cohort study.
@nl
prefLabel
Disease-modifying drug initiat ...... a retrospective cohort study.
@ast
Disease-modifying drug initiat ...... a retrospective cohort study.
@en
Disease-modifying drug initiat ...... a retrospective cohort study.
@nl
P2093
P2860
P356
P1433
P1476
Disease-modifying drug initiat ...... a retrospective cohort study.
@en
P2093
Barbara H Johnson
Cheryl A Kassed
Jay M Margolis
Kristijan Kahler
Robert Fowler
P2860
P2888
P356
10.1186/1471-2377-11-122
P577
2011-10-06T00:00:00Z
P5875
P6179
1025743249